SCHEMBL6911599

SCHEMBL6911599

S[C]S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7063166 0.67
SCHEMBL1880009 0.61
Thiocyanic Acid SCHEMBL435605 0.61
Thiocyanic Acid SCHEMBL2359454 0.61 CA1 (1.00)
SCHEMBL130101 0.61
Thiocyanic Acid SCHEMBL22439 0.61
Thiocyanic Acid SCHEMBL8900 0.61
Thiocyanic Acid SCHEMBL18153982 0.61 CA1 (1.00)
SCHEMBL11816212 0.61
SCHEMBL404959 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1377572-A1 ISOXAXOLE DERIVATIVES AS INHIBITORS OF SRC AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-01-07 EP disclosed
US-20030207873-A1 Inhibitors of Src and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED 2003-11-06 US disclosed
WO-2002083668-A1 ISOXAXOLE DERIVATIVES AS INHIBITORS OF SRC AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-10-24 WO disclosed